SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

Eric Adjei Boakye, PhD, MA Assistant Professor Department of Population Science and Policy Contact 217-545-8511 eadjeiboakye49@siumed.edu Primary Responsibilities My primary responsibilities include pursuing individual and collaborative research in human papillomavirus (HPV), HPV-associated cancers, and in cancer disparities; as well as providing education and mentoring to medical students, residents and fellows. About I received both my bachelors (Computer Information Systems) and masters (Healthcare Management) in Minnesota. Whiles working on my masters, I worked for Mayo Clinic in Rochester

REDCap is a HIPAA compliant, secure web application for building and managing online surveys and databases. REDCap can be used to collect data for many purposes, including online or offline data capture for research studies, quality improvement projects, and general administrative operations. SIU School of Medicine hosts REDCap on SIU-SOM servers. All SIU-SOM employees may request REDCap projects. REDCap is managed by the Statistics and Informatics Core within the Center for Clinical Research. The Statistics Core will set-up REDCap projects, create and maintain data entry and survey

The fall issue of the Library Newsletter is now available on our newsletter page. Vol 8, issue 4, Oct 2018

SIU School of Medicine authors published 30 articles in the past month that were added to PubMed. Display the 25 citations in PubMed

On Wednesday, September 19, Southern Illinois University School of Medicine celebrated the new Department of Population Science and Policy with an event attended by SIU Medicine Dean and Provost Dr. Jerry Kruse, Interim SIU System President Dr. Kevin Dorsey, Population Science and Policy staff, friends, community partners and other interested individuals. The event, which featured a reception and informational program, invited people to join the movement of improving health in central and southern Illinois. The program reflected on the genesis of the Department, its work to uphold the school's

SIU School of Medicine Launches Department of Population Science and Policy New department considers social determinants to improve overall health in central, southern Illinois SPRINGFIELD, ILLINOIS, Sept. 18, 2018 – The Department of Population Science and Policy – Southern Illinois University School of Medicine’s first new department in nearly three decades, aims to be a champion for rural Illinoisans. To improve the health and wellness in the 66 counties of central and southern Illinois, the department will identify community-based interventions and study how factors such as poverty, access